From: Impact of constitutional copy number variants on biological pathway evolution
 | Pathway | Source | Gene CNV | Gene total | P-value | Fst |
---|---|---|---|---|---|---|
1 | Antigen processing and presentation | KEGG | 29 | 79 | <0.001 | Â |
2 | Metabolism of xenobiotics by cytochrome P450 | KEGG | 22 | 60 | <0.001 | 0.31(CEU|YRI),0.23(YRI|CHB),0.16(CEU|CHB), |
3 | Type I diabetes mellitus | KEGG | 17 | 41 | <0.001 | Â |
4 | Keratinocyte Differentiation | BIOCARTA | 16 | 18 | <0.001 | 0.53(CEU|YRI), 0.57(YRI|CHB) |
5 | Pentose and glucuronate interconversions | KEGG | 9 | 14 | <0.001 | 0.16(CEU|CHB), 0.28(YRI|CHB) |
6 | The role of FYVE-finger proteins in vesicle transport | BIOCARTA | 6 | 7 | <0.001 | 0.12(CEU|YRI), 0.37(CEU|CHB),0.47(YRI|CHB), |
7 | Phospholipase C d1 in phospholipid associated cell signaling | BIOCARTA | 4 | 5 | <0.001 | 0.53(CEU|YRI), 0.67(YRI|CHB), |
8 | Activation of cAMP-dependent protein kinase, PKA | BIOCARTA | 2 | 3 | <0.001 | Â |
9 | B Cell Receptor Complex | BIOCARTA | 1 | 2 | <0.001 | Â |
10 | Carbazole degradation | KEGG | 1 | 1 | <0.001 | Â |
11 | Fluorene degradation | KEGG | 1 | 2 | <0.001 | Â |
12 | Inositol metabolism | KEGG | 1 | 2 | <0.001 | Â |
13 | Peptidoglycan biosynthesis | KEGG | 1 | 2 | <0.001 | Â |
14 | Segmentation Clock | BIOCARTA | 7 | 12 | 0.001 | Â |